世界の緊急避妊薬市場2023年-2027年

【英語タイトル】Global Emergency Contraceptive Pills Market 2023-2027

Technavioが出版した調査資料(IRTNTR70846-23)・商品コード:IRTNTR70846-23
・発行会社(調査会社):Technavio
・発行日:2022年12月22日
・ページ数:154
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、ヨーロッパ、アジア、その他地域
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Technavio社の本調査レポートによると、世界の緊急避妊薬市場規模が2022年から2027年まで年平均4.83%成長し、258.7百万ドルに達すると予測されています。本書では、緊急避妊薬の世界市場を調査対象とし、エグゼクティブサマリー、市場状況、市場規模予測、過去の市場規模、ファイブフォース分析、流通チャネル別(小売店、オンラインストア)分析、種類別(配合剤、プロゲステロン製剤)分析、顧客状況、地域別状況(北米、ヨーロッパ、アジア太平洋、その他地域、アメリカ、中国、ドイツ、フランス、日本)分析、推進要因・課題・動向、企業状況、企業分析などの項目を掲載しています。なお、本書には、主要企業としてAbbVie Inc.、Afaxys Pharma LLC、Bayer AG、Combe Inc.、Foundation Consumer Healthcare LLC、Gedeon Richter Plc、HLL Lifecare Ltd.、Knoll Healthcare Pvt. Ltd.、Laboratoire HRA Pharma SAS、Lupin Ltd.、Mankind Pharma Ltd.、Morepen Laboratories Ltd.、Perrigo Co. Plc、Pfizer Inc.、Piramal Enterprises Ltd.、Sun Pharmaceutical Industries Ltd.、Syzygy Healthcare LLC、Teva Pharmaceutical Industries Ltd.などの企業情報が含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模予測
・過去の市場規模
・ファイブフォース分析
・世界の緊急避妊薬市場規模:流通チャネル別
- 小売店チャネルの市場規模
- オンラインストアチャネルの市場規模
・世界の緊急避妊薬市場規模:種類別
- 配合剤の市場規模
- プロゲステロン製剤の市場規模
・顧客状況
・世界の緊急避妊薬市場規模:地域別
- 北米の緊急避妊薬市場規模
- ヨーロッパの緊急避妊薬市場規模
- アジア太平洋の緊急避妊薬市場規模
- その他地域の緊急避妊薬市場規模
- アメリカの緊急避妊薬市場規模
- 中国の緊急避妊薬市場規模
- ドイツの緊急避妊薬市場規模
- フランスの緊急避妊薬市場規模
- 日本の緊急避妊薬市場規模 
・推進要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することにより、また複数のソースからのデータを調査、統合、および合計することにより、市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査報告書は、正確な市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。

緊急避妊薬の世界市場 2023-2027

Technavio社は、緊急避妊薬市場をモニターしており、2022年から2027年にかけて258.7百万ドルの成長が予測され、予測期間中のCAGRは4.83%で加速すると予測しています。当レポートでは、緊急避妊薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを提供しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場を牽引しているのは、認知度向上のための取り組み数の増加、計画外妊娠の増加、オンライン購入の容易さなどです。

Technavioの緊急避妊薬市場は以下のように区分されます:

・流通チャネル別:
– 小売店
– オンラインストア

・タイプ別:
– コンビネーションピル
– プロゲステロン錠剤

・地域別:
– 北米
– ヨーロッパ
– アジア
– その他の地域(ROW)

本調査では、今後数年間の緊急避妊薬市場の成長を促進する主な理由の一つとして、家族計画の重要性を挙げています。また、オンラインアプリの登場と可処分所得の増加は、市場の大きな需要につながるでしょう。

Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

緊急避妊薬市場に関する弊社のレポートは以下の分野をカバーしています:
– 緊急避妊薬市場のサイジング
– 緊急避妊薬市場予測
– 緊急避妊薬市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、AbbVie Inc., Afaxys Pharma LLC, Bayer AG, Combe Inc., Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Ltd., Knoll Healthcare Pvt. Ltd., Laboratoire HRA Pharma SAS, Lupin Ltd., Mankind Pharma Ltd., Morepen Laboratories Ltd., Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., Syzygy Healthcare LLC, and Teva Pharmaceutical Industries Ltdなどの企業情報が含まれています。また、緊急避妊薬市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global emergency contraceptive pills market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global emergency contraceptive pills market 2017 – 2021 ($ million)
o 4.2 Distribution channel Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ million)
o 4.3 Type Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Retail stores – Market size and forecast 2022-2027
o Exhibit 34: Chart on Retail stores – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Retail stores – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Retail stores – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Retail stores – Year-over-year growth 2022-2027 (%)
o 6.4 Online stores – Market size and forecast 2022-2027
o Exhibit 38: Chart on Online stores – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Online stores – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Online stores – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Online stores – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Distribution Channel
o Exhibit 42: Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 43: Chart on Type – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Type – Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 45: Chart on Comparison by Type
o Exhibit 46: Data Table on Comparison by Type
o 7.3 Combination pills – Market size and forecast 2022-2027
o Exhibit 47: Chart on Combination pills – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Combination pills – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Combination pills – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Combination pills – Year-over-year growth 2022-2027 (%)
o 7.4 Progesterone pills – Market size and forecast 2022-2027
o Exhibit 51: Chart on Progesterone pills – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Progesterone pills – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Progesterone pills – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Progesterone pills – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Type
o Exhibit 55: Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 59: Chart on Geographic comparison
o Exhibit 60: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 61: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 63: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 64: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 65: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 69: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 77: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 81: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 France – Market size and forecast 2022-2027
o Exhibit 89: Chart on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 93: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 97: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 98: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 100: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 101: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 102: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 103: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 104: AbbVie Inc. – Overview
o Exhibit 105: AbbVie Inc. – Product / Service
o Exhibit 106: AbbVie Inc. – Key news
o Exhibit 107: AbbVie Inc. – Key offerings
o 12.4 Afaxys Pharma LLC
o Exhibit 108: Afaxys Pharma LLC – Overview
o Exhibit 109: Afaxys Pharma LLC – Product / Service
o Exhibit 110: Afaxys Pharma LLC – Key offerings
o 12.5 Bayer AG
o Exhibit 111: Bayer AG – Overview
o Exhibit 112: Bayer AG – Business segments
o Exhibit 113: Bayer AG – Key news
o Exhibit 114: Bayer AG – Key offerings
o Exhibit 115: Bayer AG – Segment focus
o 12.6 Combe Inc.
o Exhibit 116: Combe Inc. – Overview
o Exhibit 117: Combe Inc. – Product / Service
o Exhibit 118: Combe Inc. – Key offerings
o 12.7 Foundation Consumer Healthcare LLC
o Exhibit 119: Foundation Consumer Healthcare LLC – Overview
o Exhibit 120: Foundation Consumer Healthcare LLC – Product / Service
o Exhibit 121: Foundation Consumer Healthcare LLC – Key offerings
o 12.8 Gedeon Richter Plc
o Exhibit 122: Gedeon Richter Plc – Overview
o Exhibit 123: Gedeon Richter Plc – Business segments
o Exhibit 124: Gedeon Richter Plc – Key news
o Exhibit 125: Gedeon Richter Plc – Key offerings
o Exhibit 126: Gedeon Richter Plc – Segment focus
o 12.9 HLL Lifecare Ltd.
o Exhibit 127: HLL Lifecare Ltd. – Overview
o Exhibit 128: HLL Lifecare Ltd. – Product / Service
o Exhibit 129: HLL Lifecare Ltd. – Key offerings
o 12.10 Laboratoire HRA Pharma SAS
o Exhibit 130: Laboratoire HRA Pharma SAS – Overview
o Exhibit 131: Laboratoire HRA Pharma SAS – Product / Service
o Exhibit 132: Laboratoire HRA Pharma SAS – Key offerings
o 12.11 Lupin Ltd.
o Exhibit 133: Lupin Ltd. – Overview
o Exhibit 134: Lupin Ltd. – Product / Service
o Exhibit 135: Lupin Ltd. – Key news
o Exhibit 136: Lupin Ltd. – Key offerings
o 12.12 Mankind Pharma Ltd.
o Exhibit 137: Mankind Pharma Ltd. – Overview
o Exhibit 138: Mankind Pharma Ltd. – Product / Service
o Exhibit 139: Mankind Pharma Ltd. – Key offerings
o 12.13 Perrigo Co. Plc
o Exhibit 140: Perrigo Co. Plc – Overview
o Exhibit 141: Perrigo Co. Plc – Business segments
o Exhibit 142: Perrigo Co. Plc – Key news
o Exhibit 143: Perrigo Co. Plc – Key offerings
o Exhibit 144: Perrigo Co. Plc – Segment focus
o 12.14 Pfizer Inc.
o Exhibit 145: Pfizer Inc. – Overview
o Exhibit 146: Pfizer Inc. – Product / Service
o Exhibit 147: Pfizer Inc. – Key news
o Exhibit 148: Pfizer Inc. – Key offerings
o 12.15 Piramal Enterprises Ltd.
o Exhibit 149: Piramal Enterprises Ltd. – Overview
o Exhibit 150: Piramal Enterprises Ltd. – Business segments
o Exhibit 151: Piramal Enterprises Ltd. – Key offerings
o Exhibit 152: Piramal Enterprises Ltd. – Segment focus
o 12.16 Sun Pharmaceutical Industries Ltd.
o Exhibit 153: Sun Pharmaceutical Industries Ltd. – Overview
o Exhibit 154: Sun Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 155: Sun Pharmaceutical Industries Ltd. – Key offerings
o 12.17 Syzygy Healthcare LLC
o Exhibit 156: Syzygy Healthcare LLC – Overview
o Exhibit 157: Syzygy Healthcare LLC – Product / Service
o Exhibit 158: Syzygy Healthcare LLC – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 159: Inclusions checklist
o Exhibit 160: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 161: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 162: Research methodology
o Exhibit 163: Validation techniques employed for market sizing
o Exhibit 164: Information sources
o 13.5 List of abbreviations
o Exhibit 165: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary – Chart on Market Segmentation by Type
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global emergency contraceptive pills market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Retail stores – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Retail stores – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Retail stores – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Retail stores – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Online stores – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Online stores – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Online stores – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Online stores – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Distribution Channel ($ million)
Exhibits43: Chart on Type – Market share 2022-2027 (%)
Exhibits44: Data Table on Type – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Type
Exhibits46: Data Table on Comparison by Type
Exhibits47: Chart on Combination pills – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Combination pills – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Combination pills – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Combination pills – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Progesterone pills – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Progesterone pills – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Progesterone pills – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Progesterone pills – Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by Type ($ million)
Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits59: Chart on Geographic comparison
Exhibits60: Data Table on Geographic comparison
Exhibits61: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits62: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits63: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits65: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on France – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on France – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits97: Market opportunity By Geographical Landscape ($ million)
Exhibits98: Impact of drivers and challenges in 2022 and 2027
Exhibits99: Overview on Criticality of inputs and Factors of differentiation
Exhibits100: Overview on factors of disruption
Exhibits101: Impact of key risks on business
Exhibits102: Vendors covered
Exhibits103: Matrix on vendor position and classification
Exhibits104: AbbVie Inc. – Overview
Exhibits105: AbbVie Inc. – Product / Service
Exhibits106: AbbVie Inc. – Key news
Exhibits107: AbbVie Inc. – Key offerings
Exhibits108: Afaxys Pharma LLC – Overview
Exhibits109: Afaxys Pharma LLC – Product / Service
Exhibits110: Afaxys Pharma LLC – Key offerings
Exhibits111: Bayer AG – Overview
Exhibits112: Bayer AG – Business segments
Exhibits113: Bayer AG – Key news
Exhibits114: Bayer AG – Key offerings
Exhibits115: Bayer AG – Segment focus
Exhibits116: Combe Inc. – Overview
Exhibits117: Combe Inc. – Product / Service
Exhibits118: Combe Inc. – Key offerings
Exhibits119: Foundation Consumer Healthcare LLC – Overview
Exhibits120: Foundation Consumer Healthcare LLC – Product / Service
Exhibits121: Foundation Consumer Healthcare LLC – Key offerings
Exhibits122: Gedeon Richter Plc – Overview
Exhibits123: Gedeon Richter Plc – Business segments
Exhibits124: Gedeon Richter Plc – Key news
Exhibits125: Gedeon Richter Plc – Key offerings
Exhibits126: Gedeon Richter Plc – Segment focus
Exhibits127: HLL Lifecare Ltd. – Overview
Exhibits128: HLL Lifecare Ltd. – Product / Service
Exhibits129: HLL Lifecare Ltd. – Key offerings
Exhibits130: Laboratoire HRA Pharma SAS – Overview
Exhibits131: Laboratoire HRA Pharma SAS – Product / Service
Exhibits132: Laboratoire HRA Pharma SAS – Key offerings
Exhibits133: Lupin Ltd. – Overview
Exhibits134: Lupin Ltd. – Product / Service
Exhibits135: Lupin Ltd. – Key news
Exhibits136: Lupin Ltd. – Key offerings
Exhibits137: Mankind Pharma Ltd. – Overview
Exhibits138: Mankind Pharma Ltd. – Product / Service
Exhibits139: Mankind Pharma Ltd. – Key offerings
Exhibits140: Perrigo Co. Plc – Overview
Exhibits141: Perrigo Co. Plc – Business segments
Exhibits142: Perrigo Co. Plc – Key news
Exhibits143: Perrigo Co. Plc – Key offerings
Exhibits144: Perrigo Co. Plc – Segment focus
Exhibits145: Pfizer Inc. – Overview
Exhibits146: Pfizer Inc. – Product / Service
Exhibits147: Pfizer Inc. – Key news
Exhibits148: Pfizer Inc. – Key offerings
Exhibits149: Piramal Enterprises Ltd. – Overview
Exhibits150: Piramal Enterprises Ltd. – Business segments
Exhibits151: Piramal Enterprises Ltd. – Key offerings
Exhibits152: Piramal Enterprises Ltd. – Segment focus
Exhibits153: Sun Pharmaceutical Industries Ltd. – Overview
Exhibits154: Sun Pharmaceutical Industries Ltd. – Product / Service
Exhibits155: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibits156: Syzygy Healthcare LLC – Overview
Exhibits157: Syzygy Healthcare LLC – Product / Service
Exhibits158: Syzygy Healthcare LLC – Key offerings
Exhibits159: Inclusions checklist
Exhibits160: Exclusions checklist
Exhibits161: Currency conversion rates for US$
Exhibits162: Research methodology
Exhibits163: Validation techniques employed for market sizing
Exhibits164: Information sources
Exhibits165: List of abbreviations



★調査レポート[世界の緊急避妊薬市場2023年-2027年] (コード:IRTNTR70846-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の緊急避妊薬市場2023年-2027年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆